Lindsey Fetzer, a member in the Washington, D.C. office, represents clients in connection with government and internal investigations and litigations involving alleged violations of the False Claims Act (FCA), Anti-Kickback Statute (AKS), Foreign Corrupt Practice Act (FCPA), and other criminal and civil regulations. Lindsey has represented clients in foreign and domestic matters involving the U.S. Department of Justice (DOJ), U.S. Securities and Exchange Commission (SEC), and other primary enforcement agencies.
American Bar Association
American Health Law Association (AHLA)
Women’s White Collar Defense Association
Obtained a jury trial victory on six of seven counts for the former vice president of Pilot Flying J who, along with three others, was accused of seeking to defraud customers
Represented a global healthcare company in relation to an investigation conducted by DOJ and HHS-OIG into alleged violations of the False Claims Act. The alleged false claims involved the manner in which certain negative pressure wound therapy devices were being marketed and distributed as durable medical equipment. Conducted an internal investigation and negotiated a favorable settlement with DOJ, HHS-OIG, and counsel for the relator. No post-settlement oversight was required.
Represented a publicly-traded oilfield services company in an investigation of alleged anti-corruption violations in Africa
Conducted a multi-country FCPA and local law investigation in Southeast Asia for a U.S. company
Advised a multinational company in review of potential anti-money laundering violations
Represented ArthroCare Corporation in a five-year U.S. Department of Justice investigation into allegations of healthcare and securities fraud resulting in a Deferred Prosecution Agreement and no post-settlement monitoring.
Represented a group of diagnostic imaging centers in a U.S. Department of Justice and HHS-OIG investigation alleging False Claims Act violations. Negotiated resolution with no post-investigation monitoring or corporate integrity agreement.
Represented a publicly-traded multinational company in conducting an internal investigation and making voluntary disclosure of FCPA violations to Securities and Exchange Commission (SEC); resulted in formal declination of prosecution by the SEC
Advised a publicly traded U.S. company on anti-corruption due diligence related to the potential acquisition of a U.S. company with an active unresolved DOJ and SEC FCPA investigation
Represented a Fortune 500 U.S. automotive company in an FCPA investigation by U.S. Justice Department (DOJ) and Securities and Exchange Commission (SEC)
Best Lawyers: Ones To Watch — Health Care Law (2021)
Washington, D.C. Super Lawyers “Rising Star” (2015-2020)
Washington and Lee Journal of Civil Rights and Social Justice — Lead Articles Editor